PLUR

Pluri Inc.

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. NV · CIK 0001158780
$2.33 -10.38% $28.1M
Vol
Market Cap$28.1M
Cap SizeNano Cap
Inst. Holders4 funds
Inst. Value$70.0K
Inst. Activity1 buys / 1 sells
SEC Reports1
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. NV·CIK 0001158780·Prev Close $2.60

Recent Activity

May 11, 2026 earnings_calendar
PLUR Q3 2026 Earnings Scheduled — 2026-05-11
Apr 23, 2026 SEC
Pluri Inc. is holding its 2026 annual meeting to elect five board members and ratify the selection of its independent au
DEFA14A — Impact 2/10
Apr 21, 2026 Insider
Manieu Alexandre Weinstein sold 312,500 shares
Director @ $2.00 ($625.0K)
Apr 21, 2026 Insider
Manieu Alexandre Weinstein sold 312,500 shares
Director @ $2.00 ($625.0K)
Mar 31, 2026 Insider
Manieu Alexandre Weinstein sold 312,500 shares
Director @ $2.00 ($625.0K)
Inst.
RENAISSANCE TECHNOLOGIES LLC — TRIM
20,024 shares ($59.9K)
Inst.
BANK OF AMERICA CORP — DOUBLED
125 shares ($374.00)

Price Targets

Historical data — last covering-analyst action Jun 2025. No current recommendation available.
$12.00 (Jun 2025)
Current $2.33 Low $12.00 Median $12.00 High $12.00 1 analysts
$12.00 $12.00

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action Jun 2025
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Jun 2, 2025 Alliance Global Partners INITIATE Buy

Top Institutional Holders

FundValueMove
RENAISSANCE TECHNOLOGIES LLC$59.9KTRIM
MORGAN STANLEY$9.2KDOUBLED
WELLS FARGO & COMPANY/MN$553.00
BANK OF AMERICA CORP$374.00DOUBLED

Recent Insider Trades

DateInsiderTypeValue
Apr 21, 2026Manieu AlexandreA$625.0K
Apr 21, 2026Manieu AlexandreA$625.0K
Mar 31, 2026Manieu AlexandreA$625.0K
Mar 31, 2026Manieu AlexandreA$625.0K
4 institutional holders with $70.0K total value (23,411 shares) as of 2025-Q4. Top holders: RENAISSANCE, MORGAN, WELLS.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1RENAISSANCE TECHNOLOGIES LLC20,024$59.9K85.5%TRIM -41.0%
2MORGAN STANLEY3,077$9.2K13.1%DOUBLED +490.6%
3WELLS FARGO & COMPANY/MN185$553.000.8%
4BANK OF AMERICA CORP /DE/125$374.000.5%DOUBLED +166.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
RENAISSANCE TECHNOLOGIES LLCTRIM33,92520,024-41.0%$59.9K2025-Q4
BANK OF AMERICA CORP /DE/DOUBLED47125+166.0%$374.002025-Q4
BANK OF AMERICA CORP /DE/NEAR_EXIT25847-81.8%$211.002025-Q3
UBS Group AGTRIM6518-72.3%$81.002025-Q3
MORGAN STANLEYDOUBLED5223,083+490.6%$15.3K2025-Q2
BANK OF AMERICA CORP /DE/DOUBLED100258+158.0%$1.3K2025-Q2
UBS Group AGTRIM20765-68.6%$322.002025-Q2
UBS Group AGNEAR_EXIT7,428207-97.2%$890.002025-Q1
RENAISSANCE TECHNOLOGIES LLCADD24,62534,025+38.2%$145.5K2024-Q4
UBS Group AGDOUBLED1,3607,428+446.2%$31.8K2024-Q4
1 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Apr 21, 2026Manieu Alexandre WeinsteinDirectorA312,500$2.00$625.0K
Apr 21, 2026Manieu Alexandre WeinsteinDirectorA312,500$2.00$625.0K
Mar 31, 2026Manieu Alexandre WeinsteinDirectorA312,500$2.00$625.0K
Mar 31, 2026Manieu Alexandre WeinsteinDirectorA312,500$2.00$625.0K
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 2.0/10.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Jun 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Jun 2025. No current recommendation available.
$12.00 mean target (Jun 2025)
$12.00 Low $12.00 High
MetricValue
Current Price$2.33
Target Low$12.00
Target Mean$12.00
Target Median$12.00
Target High$12.00
# Analysts1
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2026-06-30
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Jun 2, 2025 Alliance Global Partners INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
May 1, 20262410086%
Apr 1, 20262410086%
Mar 1, 20262410086%
Feb 1, 20262410086%
Jan 1, 20262410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 11, 2026
earnings_calendar
PLUR Q3 2026 Earnings Scheduled — 2026-05-11
Mar 26, 2026
offering
Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement
<p align="justify">HAIFA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (“Pluri” or the “Company”) (Nasdaq, TASE: PLUR), a biotechnology com